Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    June 2018
  1. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
    PubMed     Text format     Abstract available


    February 2018
  2. HONG X, Sullivan RJ, Kalinich M, Kwan TT, et al
    Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.
    Proc Natl Acad Sci U S A. 2018 Feb 16. pii: 1719264115.
    PubMed     Text format     Abstract available


    January 2018
  3. TAGGART D, Andreou T, Scott KJ, Williams J, et al
    Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8(+) T cell trafficking.
    Proc Natl Acad Sci U S A. 2018 Jan 31. pii: 1714089115.
    PubMed     Text format     Abstract available


    December 2017
  4. SU Y, Wei W, Robert L, Xue M, et al
    Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1712064115.
    PubMed     Text format     Abstract available


    October 2017
  5. MGRDITCHIAN T, Arakelian T, Paggetti J, Noman MZ, et al
    Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.
    Proc Natl Acad Sci U S A. 2017;114:E9271-E9279.
    PubMed     Text format     Abstract available


    September 2017
  6. INGRAM JR, Blomberg OS, Sockolosky JT, Ali L, et al
    Localized CD47 blockade enhances immunotherapy for murine melanoma.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201710776.
    PubMed     Text format     Abstract available


    August 2017
  7. DUGGAN MC, Stiff AR, Bainazar M, Regan K, et al
    Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
    Proc Natl Acad Sci U S A. 2017 Aug 21. pii: 201704371.
    PubMed     Text format     Abstract available


    July 2017
  8. DU W, Seah I, Bougazzoul O, Choi G, et al
    Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.
    Proc Natl Acad Sci U S A. 2017 Jul 14. pii: 201700363.
    PubMed     Text format     Abstract available


  9. LUNAVAT TR, Cheng L, Einarsdottir BO, Olofsson Bagge R, et al
    BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells.
    Proc Natl Acad Sci U S A. 2017 Jul 6. pii: 201705206.
    PubMed     Text format     Abstract available


    June 2017
  10. TURRIANI E, Lazaro DF, Ryazanov S, Leonov A, et al
    Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death.
    Proc Natl Acad Sci U S A. 2017 Jun 5. pii: 201700200.
    PubMed     Text format     Abstract available


    December 2016
  11. KEGELMAN TP, Wu B, Das SK, Talukdar S, et al
    Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Proc Natl Acad Sci U S A. 2016 Dec 23. pii: 201616100.
    PubMed     Text format     Abstract available


    November 2016
  12. LI Y, Cheng HS, Chng WJ, Tergaonkar V, et al
    Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
    Proc Natl Acad Sci U S A. 2016 Nov 23. pii: 201611106.
    PubMed     Text format     Abstract available


  13. DANILOVA L, Wang H, Sunshine J, Kaunitz GJ, et al
    Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
    Proc Natl Acad Sci U S A. 2016 Nov 11. pii: 201607836.
    PubMed     Text format     Abstract available


  14. SPRANGER S, Luke JJ, Bao R, Zha Y, et al
    Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
    Proc Natl Acad Sci U S A. 2016 Nov 11. pii: 201609376.
    PubMed     Text format     Abstract available


    August 2016
  15. FATTORE L, Mancini R, Acunzo M, Romano G, et al
    miR-579-3p controls melanoma progression and resistance to target therapy.
    Proc Natl Acad Sci U S A. 2016 Aug 8. pii: 201607753.
    PubMed     Text format     Abstract available


    May 2016
  16. NAKAGAWA H, Sido JM, Reyes EE, Kiers V, et al
    Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.
    Proc Natl Acad Sci U S A. 2016;113:6248-53.
    PubMed     Text format     Abstract available


  17. DAR AA, Majid S, Bezrookove V, Phan B, et al
    BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Proc Natl Acad Sci U S A. 2016 May 16. pii: 201606027.
    PubMed     Text format     Abstract available


    April 2016
  18. ADAR S, Hu J, Lieb JD, Sancar A, et al
    Genome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis.
    Proc Natl Acad Sci U S A. 2016;113:E2124-33.
    PubMed     Text format     Abstract available


    February 2016
  19. DONDOSSOLA E, Dobroff AS, Marchio S, Cardo-Vila M, et al
    Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors.
    Proc Natl Acad Sci U S A. 2016;113:2223-8.
    PubMed     Text format     Abstract available


  20. LISSANU DERIBE Y, Shi Y, Rai K, Nezi L, et al
    Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma.
    Proc Natl Acad Sci U S A. 2016 Feb 16. pii: 201513801.
    PubMed     Text format     Abstract available


    January 2016
  21. FANG M, Hutchinson L, Deng A, Green MR, et al
    Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma.
    Proc Natl Acad Sci U S A. 2016 Jan 19. pii: 201525619.
    PubMed     Text format     Abstract available


    August 2015
  22. SANBORN JZ, Chung J, Purdom E, Wang NJ, et al
    Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination.
    Proc Natl Acad Sci U S A. 2015 Aug 18. pii: 201508074.
    PubMed     Text format     Abstract available


    June 2015
  23. WEIGELIN B, Bolanos E, Teijeira A, Martinez-Forero I, et al
    Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.
    Proc Natl Acad Sci U S A. 2015;112:7551-6.
    PubMed     Text format     Abstract available


    May 2015
  24. XUE S, Yang H, Qiao J, Pu F, et al
    Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.
    Proc Natl Acad Sci U S A. 2015;112:6607-12.
    PubMed     Text format     Abstract available


  25. SOUZA-FONSECA-GUIMARAES F, Young A, Mittal D, Martinet L, et al
    NK cells require IL-28R for optimal in vivo activity.
    Proc Natl Acad Sci U S A. 2015;112:E2376-84.
    PubMed     Text format     Abstract available


    March 2015
  26. NOJIRI T, Hosoda H, Tokudome T, Miura K, et al
    Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.
    Proc Natl Acad Sci U S A. 2015;112:4086-91.
    PubMed     Text format     Abstract available


  27. TZENG A, Kwan BH, Opel CF, Navaratna T, et al
    Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution.
    Proc Natl Acad Sci U S A. 2015;112:3320-5.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: